» Articles » PMID: 19784070

PAUF Functions in the Metastasis of Human Pancreatic Cancer Cells and Upregulates CXCR4 Expression

Overview
Journal Oncogene
Date 2009 Sep 29
PMID 19784070
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Pancreatic cancer is characterized by early metastatic spread, but the process of tumor cell dissemination is largely unknown. In this study we show that the soluble protein pancreatic adenocarcinoma upregulated factor (PAUF) has an important role in the metastasis and progression of the disease. Variations in the level of PAUF, either by overexpression or knockdown, resulted in altered migration, invasion and proliferation capacity of pancreatic cancer cells. Moreover, depletion of PAUF in metastatic cells dramatically abrogated the spread of the cells to distant organs in an orthotopic xenograft mouse model. PAUF elicited the activation of the extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and AKT intracellular signaling cascades and consequently their downstream transcription factors in an autocrine manner. Genome-wide expression analysis revealed that C-X-C chemokine receptor type 4 (CXCR4) expression was induced by PAUF overexpression but was repressed by PAUF knockdown. The PAUF-mediated increase in cancer cell motility was attenuated by the CXCR4 inhibitor, AMD3100, or by anti-CXCR4 antibody. Furthermore, immunohistochemical analysis of pancreatic tumor tissues clearly showed a significant positive correlation between PAUF and CXCR4 expression. Collectively, these findings indicate that PAUF enhances the metastatic potential of pancreatic cancer cells, at least in part, by upregulating CXCR4 expression.

Citing Articles

TGF-β-Induced PAUF Plays a Pivotal Role in the Migration and Invasion of Human Pancreatic Ductal Adenocarcinoma Cell Line Panc-1.

Lee M, Ham H, Lee J, Lee E, Chung C, Kong D Int J Mol Sci. 2024; 25(21).

PMID: 39518973 PMC: 11546992. DOI: 10.3390/ijms252111420.


Zymogen granule protein 16B (ZG16B) is a druggable epigenetic target to modulate the mammary extracellular matrix.

Lengyel M, Molnar A, Nagy T, Jdeed S, Garai I, Horvath Z Cancer Sci. 2024; 116(1):81-94.

PMID: 39489500 PMC: 11711063. DOI: 10.1111/cas.16382.


PAUF Induces Migration of Human Pancreatic Cancer Cells Exclusively via the TLR4/MyD88/NF-κB Signaling Pathway.

Youn S, Jiang F, Won H, Hong D, Kang T, Park Y Int J Mol Sci. 2022; 23(19).

PMID: 36232715 PMC: 9570212. DOI: 10.3390/ijms231911414.


Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review.

Koltai T, Reshkin S, Carvalho T, Di Molfetta D, Greco M, Alfarouk K Cancers (Basel). 2022; 14(10).

PMID: 35626089 PMC: 9139729. DOI: 10.3390/cancers14102486.


PAUF as a Target for Treatment of High PAUF-Expressing Ovarian Cancer.

Kim Y, Jiang F, Park J, Jeong H, Baek J, Hong S Front Pharmacol. 2022; 13:890614.

PMID: 35600865 PMC: 9121814. DOI: 10.3389/fphar.2022.890614.